Picture of Botanix Pharmaceuticals logo

BOT — Botanix Pharmaceuticals News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Fresh Tracks Announces $8.25 Mln Buyout Of Its Right To Receive Future Sofpironium Bromide Payments From Botanix

July 21 (Reuters) - Botanix Pharmaceuticals Ltd
 BOT.AX :
    * FRESH TRACKS ANNOUNCES $8.25 MILLION BUYOUT OF ITS RIGHT
TO
RECEIVE FUTURE SOFPIRONIUM BROMIDE PAYMENTS FROM BOTANIX
    * FRESH TRACKS THERAPEUTICS - UNDER APA AMENDMENT, BOTANIX
TO PAY
$8.25 MILLION IN CASH IN LIEU OF REMAINING AMOUNTS POTENTIALLY
PAYABLE BY BOTANIX TO CO

Source text for Eikon:  ID:nGNX55Bfgh 
Further company coverage:  BOT.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Botanix Pharmaceuticals

See all news